Glaxo Group Limited

Glaxosmithkline Intellectual Property Development Limited

Smithkline Beecham Corporation

Biota Scientific Management Pty Ltd

Glaxogrouplimited

Julie Nicole Hamblin

Paul Spencer Jones

Joelle Le

Nigel James Parr

Suzanne Elaine Keeling

Charlotte Jane Mitchell

Vipulkumar Kantibhai Patel

Andrew McMurtrie Mason

Nigel Stephen Watson

Chuen Chan

Robert John Young

Henry Anderson Kelly

Gita Punjabhai Shah

Nigel Paul King

Stefan Senger

Caroline Whitworth

Helen Elisabeth Weston

Kenneth David Down

Christopher James Lunniss

Anthony William James Cooper

Ian Robert Baldwin

Robert David Willacy

Timothy John Ritchie

Alison Judith Redgrave

Graham George Adam Inglis

Simon Gaines

Christian Alan Paul Smethurst

Paul Faulder

John Edward Robinson

Diane Mary Coe

Andrew Sharpe

Kevin James Doyle

Mika Lindvall

Niall Andrew Anderson

Martin Redpath Johnson

Caroline Mary Cook

Sebastien Andre Campos

Gemma Victoria White

Christopher David Edlin

Simon Peace

Juliet Kay Simpson

Nicholas Paul Barton

Edward Paul Cannons

Armelle Le Gall

William Henry Miller

Michael D Dowle

Colin David Eldred

Stephen Barry Guntrip

Michael David Barker

Simon John Fawcett MacDonald

Matthew Campbell

Katherine Louise Jones

Brian Evans

David George Allen

Derek Anthony Demaine

Michael David Woodrow

Stuart Holman

Yoshiaki Washio

Anthony William Dean

Sophie Marie Bertrand

Jonathan Andrew Taylor

Eric Philippe Andre Talbot

Zoe Alicia Henley

Zoe Alicia Harrison

Curt Dale Haffner

Andrew Baxter

Brian David Judkins

Tracy Jane Redfern

Mika Kristian Lindvall

Sharon Lisa Gough

The invention is directed to compounds of formula (I), and salts thereof. The compounds are inhibitors of kinase activity, in particular PI3-kinase activity. 

Oxepinopyrazole derivatives as inhibitors of P13-kinase activity

The invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.

Compounds

The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.

Chemical compounds

The present invention is directed to novel polymorphs and salts of a compound which is an inhibitor of kinase activity.

Polymorphs and salts

The present invention is directed to compounds for use in the treatment or prevention of influenza virus infection.

Indazole derivatives for use in the treatment of influenza virus infection

The present invention is directed to a polymorph of a compound and salts of a compound and polymorphs thereof, which compound is an inhibitor of kinase activity. 

[object Object]

The invention is directed to compounds of formula (I) and salts thereof. The compounds of the invention are inhibitors of PI3-kinase activity. 

The invention is directed to certain novel compounds of formula (I) and salts thereof. The compounds of the invention are inhibitors of PI3-kinase activity. 

Benzpyrazol derivatives as inhibitors of PI3 kinases

The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): And salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.

Growing community of inventors

Stevenage, United Kingdom

Julie Nicole Hamblin